M107

· Aclipse Two Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for M107, covering 2025-07-28 to 2025-07-28. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetics and Safety of M107 Orally Disintegrating Tablet in Healthy Adults [Phase 1]